TGFB1 and diabetes mellitus: Treatments with SBECD + OTX, SBECD + OTX + CHR, and SEBCD + CHR lowered TGF-β1 levels by 1.97-fold, 19.11-fold, and 6.62-fold, respectively, when compared to the Diabetes group.